(S (NP (NP (DT A) (JJ significant) (NN challenge)) (PP (IN in) (NP (NML (NNP Glioblastoma) (-LRB- -LRB-) (NNP GBM) (-RRB- -RRB-)) (NN management)))) (VP (VBZ is) (VP (VBG identifying) (NP (NP (NN pseudo-progression) (PRN (-LRB- -LRB-) (NP (NN PsP)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ benign) (ADJP (NN radiation) (HYPH -) (VBN induced)) (NN effect)) (, ,) (PP (IN from) (NP (NN tumor) (NN recurrence)))) (, ,) (PP (IN on) (NP (NP (JJ routine) (NN imaging)) (PP (VBG following) (NP (JJ conventional) (NN treatment))))))) (. .))
(S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN linked) (NP (NP (NN tumor) (NN lobar) (NN presence)) (CC and) (NP (NN laterality))) (PP (IN to) (NP (NN GBM) (NNS outcomes))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN disease) (NN etiology) (CC and) (NN progression)) (PP (IN in) (NP (NNP GBM)))) (VP (MD may) (VP (VB be) (VP (VBN impacted) (PP (IN by) (NP (NN tumor) (NN location)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (CD 74) (NN pre-treatment)) (SBAR (S (NP (NNP Glioblastoma) (NNP MRI)) (VP (VBZ scans) (PP (IN with) (NP (NML (NML (NN PsP) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (CC and) (NML (NN tumor))) (NN recurrence))) (PRN (-LRB- -LRB-) (NP (CD 41)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN analyzed))) (. .))
(S (ADVP (RB First)) (, ,) (S (VP (VBG enhancing) (NP (NN lesion)) (PP (IN on) (NP (NP (NNP Gd) (HYPH -) (NNP T1w) (NNP MRI)) (CC and) (NP (JJ peri-lesional) (NNS hyperintensities)))) (PP (IN on) (NP (NN T2w) (HYPH /) (NN FLAIR))))) (VP (VP (VBD were) (ADJP (JJ segmented) (PP (IN by) (NP (NNS experts))))) (CC and) (ADVP (RB then)) (VP (VBD registered) (PP (IN to) (NP (DT a) (NN brain) (NNS atlas))))) (. .))
(S (S (VP (VBG Using) (NP (NNS patients)) (PP (IN from) (NP (DT the) (CD two) (NNS phenotypes))))) (, ,) (NP (PRP we)) (VP (VBP construct) (NP (CD two) (NNS atlases)) (PP (IN by) (S (VP (VBG quantifying) (NP (NP (NN frequency)) (PP (IN of) (NP (NP (NN occurrence)) (PP (IN of) (S (VP (VBG enhancing) (NP (NN lesion) (CC and) (NN peri-lesion) (NNS hyperintensities)) (, ,) (PP (IN by) (S (VP (VBG averaging) (NP (NN voxel) (NNS intensities)) (PP (IN across) (NP (DT the) (NN population)))))))))))))))) (. .))
(S (NP (NP (NN Analysis)) (PP (IN of) (NP (JJ differential) (NN involvement)))) (VP (VBD was) (ADVP (RB then)) (VP (VBN performed) (PP (IN to) (S (VP (VB compute) (ADVP (RB voxel-wise)) (NP (NP (JJ significant) (NNS differences) (PRN (-LRB- -LRB-) (S (NP (NN p) (HYPH -) (NN value)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (PP (IN across) (NP (DT the) (NNS atlases))))))))) (. .))
(S (ADVP (RB Statistically)) (NP (JJ significant) (NNS clusters)) (VP (VBD were) (ADVP (RB finally)) (VP (VBN mapped) (PP (IN to) (NP (DT a) (JJ structural) (NNS atlas))) (S (VP (TO to) (VP (VB provide) (NP (NP (JJ anatomic) (NN localization)) (PP (IN of) (NP (PRP$ their) (NN location))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NN tumor) (NN recurrence)))) (VP (VBD showed) (NP (NP (NN prominence)) (PP (IN of) (NP (PRP$ their) (JJ initial) (NN tumor)))) (PP (IN in) (NP (DT the) (JJ parietal) (NN lobe))) (, ,) (SBAR (IN while) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NN PsP)))) (VP (VBD showed) (NP (NP (DT a) (JJ multi-focal) (NN distribution)) (PP (IN of) (NP (DT the) (JJ initial) (NN tumor)))) (PP (IN in) (NP (NP (DT the) (JJ frontal) (CC and) (JJ temporal) (NNS lobes)) (, ,) (NP (NN insula)) (, ,) (CC and) (NP (NN putamen))))))))))) (. .))
(S (NP (DT These) (JJ preliminary) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN lateralization)) (PP (IN of) (NP (NP (JJ pre-treatment) (NNS lesions)) (PP (IN towards) (NP (NP (JJ certain) (JJ anatomical) (NNS areas)) (PP (IN of) (NP (DT the) (NN brain)))))))) (VP (MD may) (VP (VB allow) (S (VP (TO to) (VP (VB provide) (NP (NP (JJ early) (NNS cues)) (PP (VBG regarding) (S (VP (VBG assessing) (NP (NP (NN likelihood)) (PP (IN of) (NP (NP (NN occurrence)) (PP (IN of) (NP (NN pseudo-progression)))))) (PP (IN from) (NP (NP (NN tumor) (NN recurrence)) (PP (IN on) (NP (NN MRI) (NNS scans))))))))))))))))) (. .))
